Physician Assistant · New York, NY
NPI
1528114790
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1249 5th Ave
New York, NY, 10029
Phone (212) 360-3903
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.1M
4,744 prescriptions
Company payments, 2025
$1,146
From 5 companies
Medicare prescription drug claims, 2024
In 2024, the drug Rafael A Bueno prescribed most often to Medicare patients was Atorvastatin Calcium, with 232 prescriptions and refills. In total Rafael A Bueno wrote 4,744 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 232 | 494 | 100 | $2,689 |
| Gabapentin Generic | 172 | 193 | 61 | $1,704 |
| Amlodipine Besylate Generic | 139 | 299 | 62 | $745 |
| Pioglitazone Hcl Generic | 134 | 298 | 49 | $1,227 |
| Omeprazole Generic | 126 | 201 | 53 | $1,309 |
| Meclizine Hcl Generic | 125 | 176 | 47 | $1,431 |
| Ezetimibe Generic | 104 | 214 | 40 | $2,981 |
| Metformin Hcl Generic | 102 | 209 | 48 | $495 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 93 | 206 | 36 | $852 |
| Jardiance Empagliflozin | 89 | 121 | 28 | $69K |
| Linzess Linaclotide | 81 | 99 | 23 | $50K |
| Rosuvastatin Calcium Generic | 78 | 168 | 34 | $1,206 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 76 | 162 | 37 | $123 |
| Doxepin Hcl Generic | 72 | 72 | 15 | $23K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 71 | 153 | 36 | $2,407 |
Brand drugs: 1,063 claims; generic drugs: 3,518 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael A Bueno $1,146 ($1,146 in general payments such as food, travel and fees) from 5 companies. The largest payer was Intra-Sana Laboratories with $513.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.